Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.

Slides:



Advertisements
Similar presentations
1 Off-Label Use of Medications in Workers Compensation Matthew Foster, PharmD, BCPS PMSI Clinical Services.
Advertisements

What Analgesics? Paracetamol – Aspirin Nefopam NSAIDS Opioids
Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Pharmacologic Treatments. 2 Cognitive Behavioural Therapy (CBT) Psychosocial Interventions.
Management of Pain in the Older Patient. Guideline Recommendations Pharmacologic Management of Persistent Pain in Older Persons American Geriatrics Society.
GENERALIZED ANXIETY DISORDER IN PRIMARY CARE Curley Bonds, MD Medical Director Didi Hirsch Mental Health Services Professor & Chair Charles R. Drew University.
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
CNS Depressants: Sedative-Hypnotics Chapter 6
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
EPECEPECEPECEPEC EPECEPECEPECEPEC Depression, Anxiety, Delirium Depression, Anxiety, Delirium Module 6 The Project to Educate Physicians on End-of-life.
Substance Abuse Issues in Chronic Pain Management Steven D. Passik, PhD Director, Oncology Symptom Control and Research Community Cancer Care, Inc. Indianapolis,
Copyright © 2015 Cengage Learning® 1 Chapter 19 Analgesics, Sedatives, and Hypnotics.
® Introduction Substance Abuse and Use of Opioids for Low Back Pain Nabil Aounallah, Sunand Kallumadanda, MD, Sandra Burge, PhD The University of Texas.
“Baby Blues” vs. Post-Partum Depression
Treatment of Chronic Non-Cancer Pain Ross Bryan Mercer University MS III August 2012.
Pain and Addiction: Assessment Issues Russell K. Portenoy, MD Chairman, Dept of Pain Medicine and Palliative Care Beth Israel Medical Center New York,
AM Report 6/30/10 Justin Crocker PGY-3. Functional Abdominal Pain Chronic pain disorder that is not explainable by a structural or metabolic disorder.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Slide 1 of xx Emerging Pharmacy Issues in the Texas Workers’ Compensation System Presented by Suzanne Novak, MD, PhD CEO, Austin Outcomes Research, Inc.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Basics of outpatient depression management Chris Zamani MD.
CNS Depressants: Sedative-Hypnotics Chapter 6
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.
Opiates in Chronic Pain Dr S Vas, Barnsley VTS October 2014.
Treating Behavioral and Psychological Symptoms of Dementia (BPSD) Kuang-Yang Hsieh, M.D. ph.D. Department of Psychiatry Chimei Medical Center.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Lyn Billington June 2006 Treatment of Attention Deficit/Hyperactivity Disorder Lyn Billington Deputy Pharmacy Manager Latrobe Regional Hospital.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
DRUGS OF ABUSE Reynaldo J. Lesaca, M.D. Reynaldo J. Lesaca, M.D.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
DEPRESSIVE DISORDERS IN OTHER SELECTED MEDICAL CONDITIONS FRANCIS CREED & SANTOSH K CHATURVEDI Copyright © World Psychiatric Association.
Pharmacotherapy III Fall The International Association for the Study of Pain defines pain as an unpleasant sensory and emotional experience associated.
Prescription Drugs This Lesson Plan Produced By Your Drug Demand Reduction Program 1.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Ph: Disclaimer: Information on this page is not a substitute for medical consultation.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 22 Antianxiety Drugs.
More Facts About Oxycontin Brett Morgan. Street Names OXY’s OXIES O’s Oxycoffins.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
Addiction and dependence Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Dr. Rupak Sethuraman. SPECIFIC LEARNING OBJECTIVES Various management techniques of orofacial pain Management of common orofacial pain disorders.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
NICE guidance Generalised Anxiety Disorder Alex Hill.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
What Our Patients Look Like
Current Concepts in Pain Management
Opioids for the management chronic non-cancer pain in Primary Care:
Opioids for chronic non-cancer pain? Which ones.....if any?
Cover slide.
Pediatric Psychology: An Overview
STOP! Safe Treatment of Pain
Tae Woo PARK, MD, MSC Boston university School of medicine
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
Opioid Prescribing & Monitoring
Class Medication Recommendatio n Starting dose Max dose Adequate Trial
Assessing Opioid Use Disorder, part 1
Tapering Controlled Substances Safely
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
UNDERSTANDING DRUGS AND MEDICINCES
ADDICTION
Tapering and Discontinuing Chronic Opioid Therapy
Pregabalin An Overview
Acute Pain Management & Addiction
Presentation transcript:

Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07

Outline Opioids in general Adderall Actiq NSAIDS Benzodiazepines Barbiturates Soma Anti-depressants Prialt

Opioids: How did they get so popular? These drugs were noted to treat both acute pain and cancer pain effectively This was extended to treatment of chronic pain Addiction was thought to arise only rarely during legitimate treatment of pain Tolerance could be overcome by dose escalation

Opioids: What we learned 50% of patients abandon treatment in trials because they don’t work or they have side effects Patients become refractory to treatment These drugs have significant neuroendocrine effects Behavioral problems, and often, frank addiction interfere with treatment

Opioids: Failed Treatment Is there evidence of failed treatment? - Opioid hyperalgesia - Frank tolerance What did we do in the past? - Increase the dose until tolerance is overcome

Opioids: How to avoid failed treatment Start to address the use of opioids early in treatment Rule Out Risk Factors for Possible Misuse Cage Questionnaire Screener and Opioid Assessment for Patients with Pain History of substance abuse Legal problemsHeavy Smoking CravingsMood Swings

Opioids: How to avoid failed treatment Start to address the use of opioids early in treatment Consider a Psychological Evaluation Diagnoses that have a poor outcome with opioid therapy: Conversion disorder Somatization disorder Pain disorders associated with depression and/or anxiety

Additional Steps Before a Trial Set treatment goals Document baseline pain and functional assessments Function assessments (social, physical, psychological, daily and work activities) Could the claimant be weaned? Treatment agreement

Once started: What to look for Prescriptions from a single practitioner and single pharmacy Ongoing review: Current painLeast/most pain Average painHow long before relief How long it lasts

Once started: What to look for The 4 A’s for Ongoing Monitoring Pain Relief Side Effects Physical and Psychosocial Function Occurrence of Aberrant/non-adherent Behavior

Opioids: Side Effects Constipation Nausea Dizziness Somnolence or Drowsiness Vomiting Dry Skin Itching/Pruritis

Opioids: When to continue and when to discontinue Continue: Don’t stop if it’s working Improved pain and function Return to work Discontinue No overall improvement in function Continuing pain with intolerable adverse effects

Opioids: When to continue and when to discontinue Illegal activities: diversion; forgery; arrest related to drugs Suicide attempts Threatening behavior in the office Repeated slips from the drug agreement: Suggest a consult with a physician trained in addiction

Treatment of Opioid-Related Sedation: Most Common Initially and With Dose Increases Eliminate unnecessary medications Rest Exercise Timing Opioid rotation Reducing the dose

Psychostimulants for Management of Sedation: Adderall Not recommended Data supporting the use of this treatment is lacking in clinical trials.

Actiq Ongoing review: Current pain, Least/most pain, Average pain,How long before relief, How long it lasts Not recommended for musculoskeletal pain Recommended for breakthrough cancer pain

NSAIDs There is no current evidence for long-term effectiveness for pain or function There is a risk of gastrointestinal and cardiovascular side effects GI/no CV: Non-selective +PPI or Cox-2 CV: Naproxyn if required

Benzodiazapenes Not recommended for long-term use (No more than 4 weeks) Tolerance develops rapidly

Barbituates Not recommended The potential for drug dependence is high No evidence of clinically important analgesic effect

Soma Metabolized to meprobamate: anxiolytic Main effect may be due to sedation Withdrawal symptoms may occur with abrupt withdrawal Soma-Coma: Street-drug name when used with opioids

Anti-depressants First-line treatment for neuropathic pain Possible for non-neuropathic pain Analgesia occurs within a few days Tricyclic anti-depressants SNRIs: Effexor (venlafaxine) and Cymbalta (duloxetine) Wellbutrin (bupropion)

Prialt Not recommended until all other intrathecal medication options have been exhausted Advantage: Considered non-addictive Disadvantage: Possible side effects including severe psychiatric symptoms and neurological impairment Use with caution in patients with history of depression and psychosis

Questions